Bioworkshops

Bioworkshops is a professional biologics contract development and manufacturing service, provider. They are committed to offering cost-effective and efficient outsourcing solutions to assist our global partners in shortening the time to start clinical trials and enter markets. The scope of their services includes process development, analytical development, and cGMP manufacturing. Their mission is to work with selected global partners to achieve rapid approval of clinical and commercial biologics by applying our expertise in development and manufacturing from a base in China

bioworkshops.com

Leadingpharm Medical Technology

Bioworkshops is a professional biologics contract development and manufacturing service, provider. They are committed to offering cost-effective and efficient outsourcing solutions to assist our global partners in shortening the time to start clinical trials and enter markets. The scope of their services includes process development, analytical development, and cGMP manufacturing. Their mission is to work with selected global partners to achieve rapid approval of clinical and commercial biologics by applying our expertise in development and manufacturing from a base in China

leadingpharm.com

Samsung Biologics

With proven regulatory approvals, the largest single-site capacity, and the fastest throughput, Samsung Biologics is an award-winning partner of choice and is uniquely able to provide seamless offerings from development, manufacturing to laboratory testing services at every stage for biopharmaceutical products while meeting the evolving needs of the global healthcare industry. By continuously innovating their People, Process, and Portfolio, they will fulfill their mission to become the most trusted partner to our clients, working together to achieve a "Better Life" for humanity through biomedicines

samsungbiologics.com

Avance Biosciences

Avance Biosciences is a privately owned genomic services company founded by a group of highly experienced genomic scientists, quality professionals, biotechnology service experts, and enthusiastic investors. Combined, their company’s founders have more than a century of experience in the genomic and biotechnology services industry under their belts. Their leading scientists, in their careers, have successfully designed and executed several hundred studies under the strict GLP/GMP regulations of the US FDA, European and Japanese regulatory agencies. This team has extensive knowledge and experience working with scientists, QA/QC professionals, and project managers from over 100 pharmaceutical and biotechnology companies and organizations globally

EuBiologics

EuBiologics Co., Ltd. focuses on developing vaccines against global pandemic and creating bacterial vaccine pipelines against newly emerging infectious diseases and antibiotic resistance. In addition to oral cholera vaccines, Eubiologics is in the process of developing a variety of high-quality vaccines to improve the health of children around the world and create new markets. EuBiologics provides personalized services to its customers with respect to biomedicines (vaccine and protein therapeutics) research and development and commercialization. Their services are designed to improve biological product quality and competitiveness, suited to all levels from research and development to the commercialization process

GMP Pharmaceuticals

Avance Biosciences is a privately owned genomic services company founded by a group of highly experienced genomic scientists, quality professionals, biotechnology service experts, and enthusiastic investors. Combined, their company’s founders have more than a century of experience in the genomic and biotechnology services industry under their belts. Their leading scientists, in their careers, have successfully designed and executed several hundred studies under the strict GLP/GMP regulations of the US FDA, European and Japanese regulatory agencies. This team has extensive knowledge and experience working with scientists, QA/QC professionals, and project managers from over 100 pharmaceutical and biotechnology companies and organizations globally

Porton Biologics

Porton Biopharma is focused on developing robust and efficient fermentation and purification processes to maximize product quality and yield. They accomplish this through the use of research study designs and scale-down models to optimize process conditions that can be translated through scale-up strategies to cGMP manufacturing. Their expertise in upstream and downstream process development is complemented by comprehensive analytical support, a range of process scale options, and state-of-the-art technologies. Developed in-house and with decades of experience, they are the sole manufacturer of Erwinase (Crisantaspase), an asparaginase enzyme indicated for the treatment of Acute Lymphoblastic Leukaemia (ALL), the most common form of cancer in children

VCRO

VCRO has almost two decades of experience in employing ICH GCP compliant clinical study services for IND-phase and post-marketing phase IV human research programs. IND project level from multinational, regional to local programs, VCRO all has the abundant experience to contribute to the client's clinical development. With the unique credit of being 100% inspection approval in GCP conduct for all VCRO clinical projects, they are rated as Number 1 CRO by the National Science and Technology Program (NSTP) in the year 2004, subsequently responsible for all NSTP clinical programs in GCP monitoring tasks and overall clinical consultation activities

Venturepharma

Venturepharma started as a CRO service provider in 1998 and went on to build up its commercialization capabilities in 2008. It was founded by a group of mainland Chinese scientists with overseas research and working experiences inspired by a common goal of improving the quality of Chinese people’s life by re-inventing affordable generic drugs. Venturepharma is well recognized as one of the most innovative harm houses in china. They provide excellent efficacy, safe & low price therapeutics scheme, Commit Chinese & Asian people can take and afford the world-class pharmaceutical products

WuXi AppTec

As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and healthcare industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development, and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, and cell and gene therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions